The Need for a National Strategy to Address Abuse and Misuse of Prescription Drugs in Canada: Canadian Medical Association Submission to the House of Commons Standing Committee on Health

https://policybase.cma.ca/en/permalink/policy11035

Date: 2013-11-27

Topics: Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs

1 document

Policy Type: Parliamentary submission

Date: 2013-11-27

Topics: Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs

Documents

BR2014-02.pdf

Read PDF Download PDF

Consultation on the prescription drug list: Naloxone

https://policybase.cma.ca/en/permalink/policy11847

Date: 2016-03-17

Topics: Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs

Association. Policy Document PD15-06 - Harms associated with opioids and other psychoactive prescriptions

1 document

Policy Type: Response to consultation

Date: 2016-03-17

Topics: Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs

Documents

BR2016-04.pdf

Read PDF Download PDF

Statement to the House of Commons Committee on Health addressing the opioid crisis in Canada

https://policybase.cma.ca/en/permalink/policy13936

Date: 2016-10-18

Topics: Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs; Population health/ health equity/ public health; Health care and patient safety

1 document

Policy Type: Parliamentary submission

Date: 2016-10-18

Topics: Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs; Population health/ health equity/ public health; Health care and patient safety

Documents

BR2017-15.pdf

Read PDF Download PDF